Submitted by ETC Staff on
In this article we explore the misleading rationale behind the production of biofuels as a way to alleviate the climate change. Biofuels would largely be obtained from transgenic crops, with the objective of increasing business opportunities for the gene giants.
Submitted by ETC Staff on
An estimated 30,000 people gathered at the World Social Forum in Nairobi where participants had a chance to vote for their favorite Nano-Hazard Symbol – a design that warns of the presence of engineered nanomaterials (1 nanometer = 1 billionth of a meter).
Submitted by ETC Staff on
A new report by the ETC Group concludes that the social, environmental and bio-weapons threats of synthetic biology surpass the possible dangers and abuses of biotech. The full text of the 70-page report, Extreme Genetic Engineering: An Introduction to Synthetic Biology, is available for downloading free-of-charge on the ETC Group website.
"Genetic engineering is passé," said Pat Mooney, Executive Director of ETC Group. "Today, scientists aren't just mapping genomes and manipulating genes, they're building life from scratch - and they're doing it in the absence of societal debate and regulatory oversight," said Mooney.
How we began: We began as a conversation about seeds in 1977. Four and a half decades later, we are still talking about seeds, but the world has grown infinitely more complex: new technologies have developed, economies have globalized, multinational companies have expanded their reach, and wealth and capital are concentrated in the hands of fewer and fewer giant corporations. Life itself has been manipulated, picked apart, re-assembled – and then patented.
In addition to esthetical criteria I based my choice on symbols which conveyed the impression of loose particles freely dispersing. I indeed believe that the main worry comes from material that can easily disperse and thus easily enter the human body. It should be noted that even if particles are initially embedded in a media, great care has to be taken to assess the whole cycle of life of the product so that even when it is disposed of the nano-particulate remain trapped.
Submitted by ETC Staff on
Presentation of Kathy Jo Wetter on behalf of ETC Group
Thank you for the opportunity to present the views of ETC Group. We are an international civil society organization based in Canada. Our work focuses on the social and economic impacts of emerging technologies and their implications, especially for marginalized communities. I’m based in ETC Group’s North Carolina office.
Submitted by ETC Staff on
During summer vacation 2006, the lead US environmental regulatory agency acknowledged it has approved at least 15 novel nano-scale chemicals. Earlier this year EPA sanctioned the unproven use of iron nanoparticles to clean up a pesticide dump.
Submitted by ETC Staff on
El verano pasado (2006), la Agencia de protección al ambiente de Estados Unidos dio luz verde a 15 productos químicos nanoescalares, aunque anteriormente había sancionado el uso de nanopartículas para limpiar un tiradero de plaguicidas y había prometido consultar con el público la regulación de los productos.
Submitted by Kathy Jo Wetter on
On October 10, ETC Group attended the US Food and Drug Administrations first public meeting on nanotechnology. About 40 people had signed up to make presentations, and we were each given eight minutes to say our piece to the FDAs newly-formed Nanotechnology Task Force. (You can read the text of ETC Groups presentation here.)
Submitted by Charlie on
Nano-Drug's Dirty Little Secret
Submitted by ETC Staff on
Issue: Medical applications of nano-scale technologies have the potential to revolutionize healthcare by delivering powerful tools for diagnosing and treating disease at the molecular level. But the current zeal for nano-enabled
medicines could divert scarce medical R&D funds away from essential health services and direct resources away from non-medical aspects of community health and wellbeing. Although nanomedicine is being touted as a solution to pressing health needs in the global South, it is being driven from the North and is designed primarily for wealthy markets. Using nano-scale technologies, the pharmaceutical industry’s ultimate goal is to make every person a patient and every patient a paying customer by “medicating” social ills with human performance enhancement (HyPE) drugs and devices. Nanoenabled HyPEs could usher in an era of two-tiered humans – Homo sapiens and Homo sapiens 2.0.
Submitted by Silvia Ribeiro on
On September 12 just days before Mexico celebrates its Independence Day ETC Group and several Mexican organizations held a press conference in Mexico City and declared the traditional Cry of Independence, but this time for the genetic independence of Mexican maize. It has been over five years since DNA from genetically modified maize contaminated native maize varieties in Mexico.
Submitted by Jim Thomas on
The Economist this week has a Special Report on Synthetic Biology , the new field of building artificial life forms from scratch. As is to be expected from the Economist, this is a fairly upbeat assesment of the technology that fails to mention the growing opposition to Synthetic Biology, signalled a few months ago when almost forty civil society groups, trade unions and scientific associations signed an open letter calling for caution.
Here at ETC we have been busy writing our own special report on Synthetic Biology (which we are calling 'Extreme Genetic Engineering' - watch this space!). You can expect it to be a bit more critical than the Economist.
Submitted by ETC Staff on
Submitted by ETC Group on
Submitted by ETC Staff on
In a quest to expand its corporate seed empire - Monsanto, the world's largest seed enterprise - announced yesterday that it will buy the world's leading cotton seed company, Mississippi-based (USA) Delta & Pine Land, for US$1.5 billion. Monsanto and Delta & Pine Land (D&PL) together account for over 57% of the US cotton seed market. With D&PL subsidiaries in 13 countries - including major markets such as China, India, Brazil, Mexico, Turkey and Pakistan - the takeover means that Monsanto will command a dominant position in one of the world's most important agricultural trade commodities and that millions of cotton farmers will be under increased pressure to accept genetically modified (GM) cottonseed.
Submitted by Kathy Jo Wetter on
Silvia Ribeiro*
The biotech company Ventria Biosciences sponsored tests, on babies and children hospitalized at two pediatric institutes in Peru, of two new experimental drugs derived from transgenic rice that was genetically engineered with synthetic human genes to produce artificial human milk proteins.
Submitted by ETC Staff on
Two World Bank projects, with funding from the GEF (Global Environmental Facility), propose to introduce genetically modified crops such as maize, potatoes, cassava, rice and cotton into five Latin American and four African countries that are centers of origin or diversity for these and other major food crops. Civil society organizations warn that DNA contamination from genetically modified crops poses an unacceptable risk to stable crops that are the basis of peasant economies in these regions. The multi-million dollar projects are being promoted under the guise of scientific biosafety research, but civil society organizations on both continents are calling for their immediate rejection because they threaten food sovereignty and farmer-controlled seed systems.
Submitted by ETC Staff on
Synthetic biology (the attempt to create artificial living organisms) should be self-regulated say scientists at Berkeley assembly. Civil Society organizations say "No!"
"If biologists are indeed on the threshold of synthesizing new life forms, the scope for abuse or inadvertent disaster could be huge." Nature, October 2004
Scientists working at the interface of engineering and biology - in the new field of "synthetic biology" - worry that public distrust of biotechnology could impede their research or draw attention to regulatory chasms. Synthetic biologists are trying to design and construct artificial living systems to perform specific tasks, such as producing pharmaceutical compounds or energy. In October 2004, the journal Nature warned, "if biologists are indeed on the threshold of synthesizing new life forms, the scope for abuse or inadvertent disaster could be huge." An editorial in that same issue suggested that there may be a need for an "Asilomar"-type conference on synthetic biology. In light of these concerns, scientists gathering at "Synthetic Biology 2.0" (May 20-22, 2006) at the University of California-Berkeley hope to make "significant progress" toward a "code of ethics and standards." Their actions are intended to project the message that the synthetic biologists are being pro-active and capable of governing themselves as a "community." In their view, self-governance is the best way forward to safely reap the benefits (both societal and financial) of synthetic biology. Civil Society organizations disagree.
Find out more about ETC Group, or contact us.
